A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly

Clinical trial NCT07623824 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07623824
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diagnosed With Acromegaly, Currently in the Active Stage of the Disease

Start date: 2026-05-31
Primary completion: 2029-07-31
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.